PACIRA BIOSCIENCES, INC. (PCRX) Free cash flow 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$136.7MFY2025 · since FY2016: $8.7M → $136.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $136.7M | -23.5% |
| FY2024 | $178.8M | +28.1% |
| FY2023 | $139.5M | +21.1% |
| FY2022 | $115.2M | +44.3% |
| FY2021 | $79.9M | +103.5% |
| FY2020 | $39.2M | -35.0% |
| FY2019 | $60.4M | +75.7% |
| FY2018 | $34.4M | +2419.8% |
| FY2017 | -$1.5M | -116.9% |
| FY2016 | $8.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice